<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04992455</url>
  </required_header>
  <id_info>
    <org_study_id>CHEMOTOXTOOL</org_study_id>
    <nct_id>NCT04992455</nct_id>
  </id_info>
  <brief_title>G8, VES-13 and CARG Scores in Predicting Chemotherapy Toxicity in Geriatric Cancer Patients</brief_title>
  <official_title>The Predictive Value of G8, VES-13 and CARG Scores in Treatment-related Toxicity in Geriatric Cancer Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Namik Kemal University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Namik Kemal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      All participants' medical information will be collected for use as a baseline, including&#xD;
      tumor-specific variables, nutritional status, functional status, psychological status,&#xD;
      cognitive function, social support, and comorbidities. The suitability of G8, VES-13 and CARG&#xD;
      chemotherapy risk assessment tools for elderly cancer patients was investigated.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All participants' medical information will be collected for use as a baseline, including&#xD;
      tumor-specific variables, nutritional status, functional status, psychological status,&#xD;
      cognitive function, social support, and comorbidities. G8, VES-13 and CARG toxicity scores of&#xD;
      all participating patients will be determined by two independent investigators before&#xD;
      starting chemotherapy. The suitability of these practical chemotherapy risk assessment tools&#xD;
      for cancer patients for elderly cancer patients was investigated.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>G8 (Geriatric 8) screening tool measurement</measure>
    <time_frame>15-30 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>CARG (Cancer and Aging Research Group) chemotherapy toxicity score measurement</measure>
    <time_frame>30-60 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>VES-13 (Vulnerable Elders Survey-13) measurement</measure>
    <time_frame>30-60 minutes</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Predicting Chemotherapy Related Toxicity in Elderly Patients</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Older Patients Receiving Chemotherapy</intervention_name>
    <description>No Intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Older Patients Receiving Chemotherapy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged ≥65 years&#xD;
&#xD;
          -  Localized or metastatic solid carcinoma diagnosed by histology (any type, any stage)&#xD;
&#xD;
          -  Starting a new-line (first-line, second-line or third-line) chemotherapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concurrent radiotherapy;&#xD;
&#xD;
          -  Simultaneous immunotherapy&#xD;
&#xD;
          -  Impaired language&#xD;
&#xD;
          -  Cognitive function leading to inability to complete assessments.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erdoğan S Şeber, Assoc. Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>Tekirdağ Namık Kemal University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eyyüp Çavdar, MD</last_name>
    <role>Study Director</role>
    <affiliation>Tekirdağ Namık Kemal University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tekirdağ Namık Kemal University</name>
      <address>
        <city>Tekirdağ</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 1, 2021</study_first_submitted>
  <study_first_submitted_qc>August 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 5, 2021</study_first_posted>
  <last_update_submitted>August 1, 2021</last_update_submitted>
  <last_update_submitted_qc>August 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Namik Kemal University</investigator_affiliation>
    <investigator_full_name>Asoc. Prof. Erdoğan Selçuk Şeber</investigator_full_name>
    <investigator_title>assoc prof</investigator_title>
  </responsible_party>
  <keyword>g8</keyword>
  <keyword>ves-13</keyword>
  <keyword>CARG</keyword>
  <keyword>chemotherapy-related toxicity</keyword>
  <keyword>Toxicity tool</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

